Invitae Corporation (NVTA)

NVTA was delisted on the 5th of February, 2024.

• Market cap: $25.5M

About: Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions.

Employees: 1,700